Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials

PURPOSE: We compared efficacy of trastuzumab versus no trastuzumab in patients with small (≤ 2 cm) human epidermal growth factor receptor 2 (HER2) –positive breast cancer treated in randomized trials. METHODS: A meta-analysis was conducted using data from five of the six adjuvant trastuzumab trials....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: O'Sullivan, Ciara C., Bradbury, Ian, Campbell, Christine, Spielmann, Marc, Perez, Edith A., Joensuu, Heikki, Costantino, Joseph P., Delaloge, Suzette, Rastogi, Priya, Zardavas, Dimitrios, Ballman, Karla V., Holmes, Eileen, de Azambuja, Evandro, Piccart-Gebhart, Martine, Zujewski, Jo Anne, Gelber, Richard D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534523/
https://ncbi.nlm.nih.gov/pubmed/26101239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.60.8620
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados